Bausch&Lomb Corp (BLCO)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO
Omeros Corporation (OMER)
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
Anika Therapeutics Inc. (ANIK)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quipt Home Medical Corp (QIPT)
Quipt Home Medical Reports Fiscal Second Quarter 2025 Results
Travere Therapeutics, Inc (TVTX)
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ascendis Pharma (ASND)
New 4-Year Data Shows Sustained Response toTransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
9 Meters Biopharma, Inc. (NMTRQ)
What Is New in iOS 18.5 and iPadOS 18.5: Key Features and Updates
United Therapeutics Corporation (UTHR)
UTHR: Notification
Context Therapeutics Inc. (CNTX)
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Perspective Therapeutics Inc (CATX)
Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results